OriolaCHIX:ORIOLH 46 EV-to-FCF is 30.43 as of Jun. 26, 2026, which is 264% above its 10-year median of 8.36. GuruFocus rates CHIX:ORIOLH with a GF Score™ of 46/100 and a GF Value™ of €1.00 (Fairly Valued). The stock has 5 warning signs investors should review. Among 410 Healthcare Providers & Services companies, Oriola ranks worse than 73.41% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Oriola's Enterprise Value is €106 Mil.
Oriola's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was €4 Mil. Therefore, Oriola's EV-to-FCF for today is 30.43.
The historical rank and industry rank for Oriola's EV-to-FCF or its related term are showing as below:
CHIX:ORIOLh'
s EV-to-FCF Range Over the Past 10 Years
Min: -12.57 Med: 8.36 Max: 2709.89
Current: 30.17
During the past 13 years, the highest EV-to-FCF of Oriola was 2709.89. The lowest was -12.57. And the median was 8.36.
CHIX:ORIOLh's EV-to-FCF is ranked worse than 73.41% of 410
companies
in the Healthcare Providers & Services industry
Industry Median: 17.435
vs CHIX:ORIOLh: 30.17
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
As of today (2026-06-26), Oriola's stock price is €0.938.
Oriola's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was €-0.130. Therefore, Oriola's PE Ratio (TTM) for today is At Loss.
Oriola (CHIX:ORIOLh) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Oriola's share price for today is €0.938.
Oriola's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.130.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Oriola EV-to-FCF Related Terms
Oriola EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Oriola's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Oriola's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oriola EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Oriola's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Oriola's EV-to-FCF falls into.
Oriola's current Enterprise Value is €106 Mil.
Oriola's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oriola (CHIX:ORIOLH) has a EV-to-FCF of 30.43 as of Jun. 26, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Oriola and its competitors. This is 264% above median its historical median of 8.36. According to the industry distribution chart, Oriola ranks #301 out of 410 companies in the Healthcare Providers & Services industry, placing it in the top 73.4%.
Is Oriola's EV-to-FCF too high?
Oriola's current EV-to-FCF of 30.43 is 264% above median its 10-year median of 8.36. The Healthcare Providers & Services industry median EV-to-FCF is 17.44. Oriola's value of 30.43 is 74.5% above this industry median. Based on the distribution chart, Oriola ranks #301 out of 410 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Oriola has a GF Score™ of 46/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Oriola's EV-to-FCF compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Oriola ranks #301 out of 410 companies for EV-to-FCF. This places Oriola in the lower half of its industry. The industry median EV-to-FCF is 17.44. Oriola's value of 30.43 is 74.5% above this benchmark. While the company's 10-year median is 8.36 vs. the industry median of 17.44, Oriola has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.44, based on 410 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Oriola's current EV-to-FCF of 30.43 is 74.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Oriola and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oriola's current EV-to-FCF is 30.43, which is 264% above median its own 10-year median of 8.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oriola stock overvalued right now?
Based on GuruFocus' analysis, Oriola (CHIX:ORIOLH) is currently considered Fairly Valued. The stock's GF Value™ is €1.00, compared to a current price of €0.94 — trading 6.2% below its estimated fair value. The current EV-to-FCF is 30.43, which is 264% above median its 10-year median of 8.36 and 74.5% above the Healthcare Providers & Services industry median of 17.44. Oriola's overall GF Score™ is 46/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Oriola (CHIX:ORIOLH), the current EV-to-FCF is 30.43 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Oriola (CHIX:ORIOLH) Overvalued in 2026?
Based on GuruFocus' analysis, Oriola stock appears to be undervalued.
The current stock price of €0.94 is trading 6.2% below its estimated GF Value™ of €1.00.
GuruFocus considers Oriola to be Fairly Valued.
Key valuation signals for CHIX:ORIOLH:
EV-to-FCF: 30.43 (264% above median its 10-year median of 8.36)
GF Value™: €1.00 vs. price of €0.94 (6.2% below fair value)
Industry Position: 74.5% above the Healthcare Providers & Services median (#301 of 410)
No single metric tells the full story. See the CHIX:ORIOLH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Oriola Corp is a health and wellbeing company operating in Nordic countries. It offers services such as the distribution of pharmaceuticals and other health and well-being products, services, and dose dispensing. Oriola's operations are divided into two segments which include distribution and wholesale. Geographically, the company operates in Sweden, Finland and other countries generating majority revenue from the region of Sweden.
46GF Score
Get the complete analysis for CHIX:ORIOLH
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:ORIOLH has been successfully added to your 
